4//SEC Filing
Panzara Michael A. 4
Accession 0000899243-20-005351
CIK 0001631574other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 6:26 PM ET
Size
5.6 KB
Accession
0000899243-20-005351
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Sale
Ordinary Shares
2020-02-18$7.85/sh−2,981$23,401→ 39,349 total
Footnotes (2)
- [F1]On February 18, 2020, the reporting person sold 2,981 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2020. These sales were made pursuant to a 10b5-1 Trading Plan.
- [F2]The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $7.84 to $8.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001679039
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 6:26 PM ET
- Size
- 5.6 KB